Opendata, web and dolomites
H2020 projects about "efficacious"
The page lists 50 projects related to the topic "efficacious".
| # | |||
|---|---|---|---|
| 1 | PROCROP | Professional cross-priming for ovary and prostate cancer | 2015 |
| 2 | SO-CMA | Improving the safety of oral immunotherapy for cow's milk allergy in children | 2016 |
| 3 | TARGEPILIVER | Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs. | 2015 |
| 4 | VETBIOMAT | Advanced material for the regeneration of joints in veterinary medicine | 2015 |
| 5 | PCMPS | Precision Cancer Medicine Pipeline and Services | 2015 |
| 6 | JointPrinting | 3D Printing of Cell Laden Biomimetic Materials and Biomolecules for Joint Regeneration | 2015 |
| 7 | MucoVac | Unravelling the mode of action of mucosal adjuvants | 2016 |
| 8 | ALKATRAS | ALK Activation as a target of TRAanslational Science (ALKATRAS): Break free from cancer | 2015 |
| 9 | PAINSTRAT | Novel neurophysiological techniques to quantify pain and stratify patients | 2016 |
| 10 | NEWROFEED | Personalized medical device for the diagnosis and treatment of ADHD based on EEG biomarkers and Neurofeedback Training | 2015 |
| 11 | U-PGx | Ubiquitous Pharmacogenomics (U-PGx): Making actionable pharmacogenomic data and effective treatment optimization accessible to every European citizen | 2016 |
| 12 | GTCMR | Global Terrorism and Collective Moral Responsibility: Redesigning Military, Police and Intelligence Institutions in Liberal Democracies | 2016 |
| 13 | VADEMA | Doctoral Industrial School for Vaccine Design through Structural Mass Spectrometry | 2016 |
| 14 | GCG-T3 Dyslipidemia | Validation and Molecular Characterization of Novel Glucagon-Thyroid Hormone Conjugates for the Efficient Management of Dyslipidemia and Fatty Liver Disease | 2016 |
| 15 | HOW2WALKAGAIN | Mechanisms of recovery after severe spinal cord injury | 2016 |
| 16 | HepatoMetaboPath | Cellular and molecular mechanisms of metabolic immune activation triggering non-alcoholic steatohepatitis (NASH) and HCC | 2016 |
| 17 | MULTIFUNSOME | Anti-EGFR Monoclonal Antibody Conjugated Thermoresponsive Liposome for Triple Negative Breast Cancer Thermo-Chemotherapy | 2017 |
| 18 | REMIND | The use of computational techniques to Improve compliance to reminders within smart environments | 2017 |
| 19 | ImpleMentAll | Towards evidence-based tailored implementation strategies for eHealth | 2017 |
| 20 | ALIVER | Development of DIALIVE, a novel Liver Dialysis Device for the treatment of patients with Acute on Chronic Liver Failure (ACLF) | 2017 |
| 21 | MOUSSE | Multilingual, Open-text Unified Syntax-independent SEmantics | 2017 |
| 22 | IC_IL_EC_2017 | Investigating the effects of immunogenic chemoradiation in shaping the immune landscape of esophageal cancers | 2018 |
| 23 | ZECARDIO | Cardiotoxicity High-throughput screening (HTS) with zebrafish embryo | 2017 |
| 24 | MEDIVAC | Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems | 2017 |
| 25 | ITCC-P4 | ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 | 2017 |
| 26 | CLINGLIO | A Clinical Phase IIB trial with 2OHOA in patients with newly-diagnosed malignant glioma. | 2017 |
| 27 | IGpath | Dissecting the functional pathways of B cell receptor immunoglobulin in antigen driven mature B cell lymphomas | 2018 |
| 28 | ENGEMED | Simulating the dynamics of viral evolution: A computer-aided study toward engineering effective vaccines | 2018 |
| 29 | XCell | A reliable, effective ballast water management system through unique in situ biocide production | 2018 |
| 30 | RAPID | RNA particles for Preparedness against Infectious Diseases | 2018 |
| 31 | STINTS | Skin Tissue INTegrity under Shear | 2019 |
| 32 | iProg | Tailored cell-based therapies for frontotemporal dementia and related genetically defined CNS orphan indications | 2018 |
| 33 | NUMA-SCALE | Enabling Large-Scale GMP-ready Peptide Production with a new, reliable and cost-efficient Bioprocess | 2018 |
| 34 | CancerQR | Next generation cancer therapies targeting cancer networks | 2019 |
| 35 | IM2PACT | Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain | 2019 |
| 36 | NOVIRUSES2BRAIN | ''One size fits all'' unique drug to eradicate multiple viral species simultaneously from the central nervous system of co-infected individuals | 2019 |
| 37 | LYMPHVECs | Development of lipid nanoparticles based on solid matrix for Benznidazole oral delivery targeting to the lymphatic system to treat Chagas disease | 2019 |
| 38 | EJP RD | European Joint Programme on Rare Diseases | 2019 |
| 39 | ProDelivery | High Throughput Synthesis of Polymeric Vesicles for Protein Delivery | 2019 |
| 40 | GT-GM1 | Ex vivo gene therapy for GM1-gangliosidosis | 2020 |
| 41 | HELP | Collaboration for innovation: Establishment of a pan-nematode drug development platform | 2019 |
| 42 | VASA | Vaccine Against Schistosomiasis for Africa. A Phase I clinical study of the SchistoShield® anti-schistosomiasis vaccine in adults in endemic areas of sub-Saharan Africa | 2019 |
| 43 | CAN-IT-BARRIERS | Disruption of systemic and microenvironmental barriers to immunotherapy of antigenic tumors | 2020 |
| 44 | ACoDM | Affective Control of Decision Making | 2019 |
| 45 | Anti-L1CAM | Anti-L1CAM antibody: A novel efficacious immunotherapy for pancreatic and ovarian cancer patients | 2019 |
| 46 | RetroChrom | Deciphering the molecular mechanisms of HIV DNA nuclear import and the impact of 3D genome organization on integration site selection | 2019 |
| 47 | PsoraxPlan | A feasibility study on the development of Psorax35 as the first and only oral treatment for mild-to-moderate psoriasis with positive effects on co-morbidities. | 2019 |
| 48 | HyperCube | HyperCube: Gram scale production of ferrite nanocubes and thermo-responsive polymer coated nanocubes for medical applications and further exploitation in other hyperthermia fields | 2020 |
| 49 | Trep-AB | Repurposing clinically approved antibacterial drugs for treponematoses therapy | 2020 |
| 50 | DLD-PI | Developmental Language Disorder - Prevention and Intervention | 2021 |